Simple choline esters as potential anti-Alzheimer agents

Current Pharmaceutical Design

Volumn 16, Issue 6, 2010, Pages 692-697

  Alcaro, Stefano ^a   Arcone, Rosaria ^a   Costa, Giosuè ^a   De Vita, Daniela ^b   Iannone, Michelangelo ^c   Ortuso, Francesco ^a   Procopio, Antonio ^a   Pasceri, Raffaele ^a   Rotiroti, Domenicantonio ^a   Scipione, Luigi ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

Alzheimer's disease; Choline esters; Electrocortical activity; Enzymatic inhibition; Molecular modelling

Indexed keywords

ACETYLCHOLINESTERASE; BUTYRRYLCHOLINESTERASE; CHOLINE ESTER; CHOLINESTERASE; ESTER DERIVATIVE; PIVALOYL LEAD ESTER; UNCLASSIFIED DRUG; CHOLINE; CHOLINESTERASE INHIBITOR; ENZYME INHIBITOR; ESTER;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CATALYSIS; CONTROLLED STUDY; ELECTROCARDIOGRAM; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROLYSIS; IN VIVO STUDY; MALE; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; THEORETICAL MODEL; ANALOGS AND DERIVATIVES; ANIMAL; BINDING SITE; COMPARATIVE STUDY; DRUG EFFECTS; ELECTROPHORUS; ENZYMOLOGY; HORSE; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; ANIMALS; BINDING SITES; BUTYRYLCHOLINESTERASE; CHOLINE; CHOLINESTERASE INHIBITORS; ELECTROPHORUS; ENZYME INHIBITORS; ESTERS; HORSES; MALE; RATS; RATS, WISTAR;

EID: 77950241009     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790883796     Document Type: Article

References (36)

1. Bartus RT, Dean RL 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217:408-17.
2. Katzman R. Medicinal progress in Alzheimer's disease. N Engl J Med 1986; 314: 964-973
3. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer's disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981; 10: 122-126
4. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215: 1237-1239
5. Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain cholinesterases in senile dementia of the Alzheimer type. Neuropathol Appl Neurobiol 1978; 4: 273-277
6. Ladner CJ, Lee JM. Pharmacological treatment of Alzheimer's disease: the cholinergic hypothesis revisited. J Neuropathol Exp Neurol 1998; 57: 719-731
7. Krall WJ, Sramek JJ, Cutler NR. Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease. Ann Pharmacother 1999; 33: 441-450
8. Schneider LS. Treatment of Alzheimer's disease with cholinesterase inhibitors. Clin Geriatr Med 2001; 17: 337-358
9. Beier MT. Treatment strategies for the behavioral symptoms of Alzheimer ' s disease : focus on early pharmacologic intervention. Pharmacotherapy 2007; 27: 399-411.
10. Belluardo N, Mudò G, Blum M, Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav Brain Res 2000; 113: 21-34.
11. French SJ, Humby T, Horner CH, Sofroniew MV, Rattray M. Hyppocampal neurotrophin and Trk receptors mRNA levels are altered by local administration of nicotine, carbachol and pilocarpine. Mol Brain Res 1999; 67: 124-136
12. Jonnala RR, Buccafusco JJ. Relationship between the increased cell surface α7 nicotinic receptors expression and neuroprotection induced by several nicotinic receptor agonists. J Neurosci Res 2001; 66: 565-572
13. Jonnala RR, Graham JH 3rd, Terry AV Jr, Beach JW, Young JA, Buccafusco JJ. Relative levels of cytoprotection produced by analogs of choline and the role of α7 nicotinic acetylcholine receptors. Synapse 2003; 47: 262-269
14. Uteshev VV, Meyer EM, Papke RL. Regulation of neuronal function by choline and 4OHGTS-21 through α7-nicotinic receptors. J Neurophisiol 2003; 89: 1797-1806
15. Yamashita H, Nakamura S. Nicotine rescue PC12 cells from death induced by nerve growth factor deprivation. Neurosci Lett 1996;213: 145-147
16. Alcaro S, Scipione L, Ortuso F, Posca S, Rispoli V, Rotiroti D. Molecular modeling and enzymatic studies of the interaction of a choline analogue and acetylcholinesterase. Bioorg Med Chem Lett 2002; 12: 2899-2905
17. Carelli V, Liberatore F, Scipione L, Rotiroti D, Rispoli V, Cardellini M. Preparation of cholinyl pivalate salts for the treatment of Alzheimer's disease and other dementia associated with a central cholinergic deficit. PCT Int Appl (2001), WO 2001081296 A1 20011101.
18. Rispoli V, Rotiroti D, Carelli V, Liberatore F, Scipione L, Marra R, et al. Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or lesions of the nucleus basalis of Meynert. Neurosci Lett 2004; 356: 199-202.
19. Rispoli V, Rotiroti D, Carelli V, Liberatore F, Scipione L, Marra R, et al. Electroencephalographic effects induced by choline pivaloyl esters in scopolamine treated or nucleus basalis magnocellularis lesioned rats. Pharmacol Biochem Behav 2004;78: 667-673
20. Rispoli V, Marra R, Costa N, Scipione L, Rotiroti D, De Vita D, et al. Choline pivaloyl ester strengthened the benefit effects of Tacrine and Galantamine on electroencephalographic and cognitive performances in nucleus basalis magnocellularis lesioned and aged rats. Pharmacol Biochem Behav 2006; 84: 453-467
21. Rispoli V, Marra R, Costa N, Rotiroti D, Tirassa P, Scipione L, et al. Choline pivaloyl ester enhances brain expression of both nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis. Behav Brain Res 2008; 190: 22-32.
22. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, et al. Automated docking using a lamarckian genetic algorithm and and empirical binding free energy function. J Comp Chem 1998; 19: 1639-1662
23. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res 2000; 28: 235-242
24. Rydberg EH, Brumshtein B, Greenblatt HM, Wong DM, Shaya D, Williams LD, et al. Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge. J Med Chem 2006; 49: 5491-5500
25. Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F. Crystal structure of human butyrrylcholinesterase and of its complexes with substrate and products. J Biol Chem 2003; 278: 41141-41147
26. MacroModel ver 7.2, Schrodinger Inc., Portland, OR, 1998-2001.
27. Alcaro S, Ortuso F, Coleman RS. Molecular modeling of DNA cross-linking analogues based on the azinomycin scaffold. J Chem Inf Model 2005; 45: 602-609
28. Alcaro S, Gasparrini F, Incani O, Mecucci S, Misiti D, Pierini M, et al. A quasi-flexible automatic docking processing for studying stereoselective recognition mechanisms. Part I. Protocol validation. J Comput Chem 2000; 21: 515-530
29. Alcaro S, Gasparrini F, Incani O, Caglioti L, Pierini M, Villani C. Quasi flexible automatic docking processing for studying stereoselective recognition mechanisms, part 2: Prediction of ΔΔG of complexation and 1H-NMR NOE correlation. J Comput Chem 2007; 28: 1119-1128
30. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of. acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
31. SigmaPlot Systat Software, Inc. Chicago, IL 1982-2009.
32. Dixon M. The determination of enzyme inhibitor constants. Biochem J 1953; 55: 170-171
33. 3 receptor ligands based on pyrroloquinoline structure and provided with acetylcholinesterase inhibitory activity. Med Chem Res 2003; 12: 147-160
34. 3 Receptor Ligand Showing Potent Acetylcholinesterase Inhibitory Properties. J Med Chem 2005; 48: 3564-3575
35. Alcaro S, Arcone R, Vecchio I, Ortuso F, Gallelli A, Pasceri R, et al. Molecular Modeling and Enzymatic Studies of Acetyl-cholinesterase and Butyrrylcholinesterase recognition with Paraquat and related compounds. SAR QSAR Environ Res 2007; 18: 595-602.
36. Coleman ME, Holland WC. Vasopressor activity of cycloalkane carbonylcholines. J Pharmacol Exp Ther 1964; 144: 214-217